Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 8NIH 4NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 2Thoracic 1Plasma cell 1Head & Neck 1Genitourinary 1Gastrointestinal 1Classical hematology 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 168Lung Neoplasms 148Adenocarcinoma of Lung 37Small Cell Lung Carcinoma 23Adenocarcinoma, Bronchiolo-Alveolar 20Breast Neoplasms 15Mesothelioma, Malignant 13Colorectal Neoplasms 11Colonic Neoplasms 10Prostatic Neoplasms 9Rectal Neoplasms 7Ovarian Neoplasms 7Breast Neoplasms, Male 7Neoplasm Metastasis 6Melanoma 6Carcinoma, Ovarian Epithelial 6Thymoma 5Pleural Effusion, Malignant 5Stomach Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Pain 4Neoplasms 4Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Salivary Gland Neoplasms 3Lymphoma, Large B-Cell, Diffuse 3Head and Neck Neoplasms 3Fallopian Tube Neoplasms 3Esthesioneuroblastoma, Olfactory 3Esophageal Neoplasms 3

Interventions

Radiotherapy 1Paclitaxel 1Filgrastim 1Carboplatin 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Drug-Related Side Effects and Adverse Reactions × Thoracic × Clear all
NCT00003313 2014-11-21

Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer

Radiation Therapy Oncology Group

Phase 3 Completed
243 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Radiation Injuries, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡